Table 3: IL-10 and IL-12 serum expression in chronic liver disease with HCV infection.

+ve HCV-chronic liver disease−ve HCV-chronic liver diseaseNDC
PCHLCHCCTotalPCHLCHCCTotal

IL-10
(ng/mL)
6.437
± 0.518
14.49
± 0.615
16.39
± 1.015
13.169
± 4.02
6.6
± 1.13
13.0
± 0.14
15.4
± 1.16
12.61
± 3.95
6.04 ± 0.568

IL-12
(ng/mL)
484.875
± 16.23
501.86
± 19.1
656.45
± 17.1
549.27
± 79.15
499.0
± 22.63
533.5
± 2.12
658.25
± 27.035
587.3
± 79.5
258.4 ± 14.06

IL-10 expression showed significant difference in HCV-infected () and noninfected patients () compared to nondisease control.
IL-12 expression showed significant difference in HCV-infected and noninfected patients () compared to nondisease control.
+ve HCV-chronic liver disease shows that there is asymptotic significance () within groups (Kruskal-Wallis test) and the difference between groups was detected by Mann-Whitney showing that there is a significant () difference between each group and the other one.